Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
78.78
+1.38 (1.78%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Haemonetics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Net Income | 97.31 | 167.68 | 117.56 | 115.4 | 43.38 |
Depreciation & Amortization | 111.72 | 115.59 | 97.22 | 93.31 | 97.75 |
Stock-Based Compensation | 33.83 | 29.64 | 28.33 | 25.58 | 24.36 |
Other Adjustments | 74.02 | -29.21 | 13.35 | 13.26 | 21.96 |
Change in Receivables | -14.88 | 6.96 | -24.19 | -24.42 | -34.97 |
Changes in Inventories | 47.36 | -64.7 | -60.06 | 30.75 | 24.31 |
Changes in Accounts Payable | -16.57 | -19.21 | 44.58 | 39.82 | 7.64 |
Changes in Income Taxes Payable | -4.53 | 0.23 | -0.98 | 1.69 | 2.87 |
Changes in Other Operating Activities | -35.03 | -25.23 | -34.05 | -22.33 | -15.02 |
Operating Cash Flow | 293.22 | 181.73 | 181.75 | 273.06 | 172.26 |
Operating Cash Flow Growth | 61.35% | -0.01% | -33.44% | 58.51% | 58.32% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Capital Expenditures | -32.78 | -39.28 | -38.13 | -191.33 | -96.51 |
Sale of Property, Plant & Equipment | 1.38 | 23.25 | 1.81 | 1.61 | 2.02 |
Cash Acquisitions | -60.18 | -150.91 | -243.85 | -2.85 | -2.5 |
Proceeds from Business Divestments | - | 43.29 | 1.5 | 0.85 | 10.64 |
Other Investing Activities | -87.96 | -38.26 | -43.72 | 47.93 | 51.8 |
Investing Cash Flow | -179.55 | -161.9 | -322.39 | -143.79 | -86.35 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Long-Term Debt Issued | 300 | 950 | 110 | 330 | - |
Long-Term Debt Repaid | -306.25 | -502.69 | -72.25 | -339.63 | -17.5 |
Net Long-Term Debt Issued (Repaid) | -6.25 | 447.31 | 37.75 | -9.63 | -17.5 |
Issuance of Common Stock | 7.89 | 8.33 | 7.21 | 7.02 | 6.55 |
Repurchase of Common Stock | -180 | -235.24 | -5.89 | -75 | - |
Net Common Stock Issued (Repurchased) | -172.11 | -226.91 | 1.33 | -67.98 | 6.55 |
Other Financing Activities | -0.1 | -111.58 | -0.92 | -22.76 | -4.8 |
Financing Cash Flow | -178.46 | 108.82 | 38.16 | -100.36 | -15.75 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Foreign Exchange Rate Adjustments | 3.46 | -0.69 | -3.19 | -3.94 | -2.98 |
Net Cash Flow | -61.32 | 127.96 | -105.67 | 24.97 | 67.19 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Free Cash Flow | 260.44 | 142.45 | 143.63 | 81.73 | 75.75 |
Free Cash Flow Growth | 82.83% | -0.82% | 75.73% | 7.89% | 5.56% |
FCF Margin | 19.52% | 10.47% | 10.97% | 6.99% | 7.63% |
Free Cash Flow Per Share | 5.50 | 2.81 | 2.79 | 1.59 | 1.48 |
Levered Free Cash Flow | 161.22 | 582.38 | 163.89 | 57.68 | 46.91 |
Unlevered Free Cash Flow | 189.29 | 142.77 | 136.22 | 79.24 | 76.08 |